Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Preface WOW. We are absolutely elated with the performance of our last swing move on SCYX. In case you missed it on … [Read more...] about MS Identified Its Next Swing
Swing Trades
SCYX Swing Move
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Swing Thesis SCYNEXIS (Nasdaq: SCYX $.73) has been identified as a potentially lucrative swing move. … [Read more...] about SCYX Swing Move
Shorts Fighting To Keep CPRX from Gaining Momentum-Insiders Aren’t Phased
After a little research it appears that shorts are working overtime to hold Catalyst Pharmaceuticals (Nasdaq: CPRX) under $3.0. Only 5 days ago we were at $3.20. A month ago and before the PDUFA date … [Read more...] about Shorts Fighting To Keep CPRX from Gaining Momentum-Insiders Aren’t Phased
A Question about ACRX price decline after Dsuvia approval
Question by deadpool from StockTwits: Q: "how do you feel about ACRX price action today seems like just a red market is tearing everything down. i am hopeful we get back up to 3.30s next week" Thanks … [Read more...] about A Question about ACRX price decline after Dsuvia approval
CPRX Swing Move For November 2018
Investment Overview MSMM believes Catalyst Pharmaceuticals (Nasdaq: CPRX $2.88) is a good swing-move for the remainder of November of 2018. The company has a PDUFA action date on November 28th … [Read more...] about CPRX Swing Move For November 2018
Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It
MS Money Moves Swing thesis for AcelRX Pharma (ACRX) published last week in our "Swing Alert"article played out nicely. ACRX spiked ~70% from $2.90 to $4.92 in the last 5 trading sessions. The upward … [Read more...] about ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It
SWING ALERT
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Swing Thesis ACRX traded last around $2.90 and has entered oversold territory. It has a FDA advisory committee meeting (ADCOM) scheduled for 10/12/2018 and a … [Read more...] about SWING ALERT
Swing Trading a Biotech Stock
Overview Swing Trading is a trading strategy that involves buying a stock at a lower price and selling it at a higher price over a short period of time. Return on investment targets ranges from … [Read more...] about Swing Trading a Biotech Stock
GALT is Strong Buy: Oversold and Cancer Catalyst Imminent
Galectin Therapeutics (NASDAQ: GALT $3.80) GALT is our number 1 stock pick for August, 2018. After a fundamental analysis we conclude the scientific data is credible & compelling, GALT is … [Read more...] about GALT is Strong Buy: Oversold and Cancer Catalyst Imminent
You must be logged in to post a comment.